Announce Date | 07/30/2025 |
EPS Normalized Actual | $1.71 (Beat by $0.1) |
EPS GAAP Actual | $1.71 (Beat by $0.1) |
Revenue Actual | $1.49109B |
Revenue Surprise | Beat by $1491.09M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $1.79547 |
EPS GAAP Estimate | $1.79547 |
Revenue Estimate | $1.277719714B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.41 | -0.25564 | 1.49109B | 1.73% | 245.11M |
FQ1 2025 (Mar 2025) | 0.42 | -1.21858 | 1.46903B | 3.49% | 196.54M |
FQ4 2024 (Dec 2024) | 0 | 0 | 1.34825B | 16.11% | 1348.25M |
FQ3 2024 (Sep 2024) | 1.43 | 1.43 | 1.47586B | 100% | 1475.86M |
FQ2 2024 (Jun 2024) | 1.59 | 1.59 | 1.46526B | 100% | 1465.26M |
FQ1 2024 (Mar 2024) | 1.57 | 1.57 | 1.41769B | 100% | 1417.69M |
FQ4 2023 (Dec 2023) | 1.79 | 1.79 | 1.131B | 100% | 1131M |
FQ4 1993 (Oct 1993) | 0.0689 | 0.0689 | 0.028B | 100% | 28M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
1.79547
Consensus Revenue Estimates
1.277719714B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.60254 | -- | 3.60254 | 3.60254 | 1 |
FQ3 2027 (Sep 2027) | 2.487 | -- | 2.487 | 2.487 | 1 |
FQ2 2027 (Jun 2027) | 2.4819 | -- | 2.4819 | 2.4819 | 1 |
FQ1 2027 (Mar 2027) | 2.45157 | -- | 2.45157 | 2.45157 | 1 |
FQ4 2026 (Dec 2026) | 2.7525 | -- | 2.7525 | 2.7525 | 1 |
FQ3 2026 (Sep 2026) | 2.149 | -- | 2.149 | 2.149 | 1 |
FQ2 2026 (Jun 2026) | 2.057 | 31.45 | 2.057 | 2.057 | 1 |
FQ1 2026 (Mar 2026) | 2.10991 | 80.09 | 2.10991 | 2.10991 | 1 |
FQ4 2025 (Dec 2025) | 2.43255 | -- | 2.43255 | 2.43255 | 1 |
FQ3 2025 (Sep 2025) | 1.79547 | 20.36 | 1.79547 | 1.79547 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.9B | -- | 1.9B | 1.9B | 1 |
FQ3 2027 (Sep 2027) | 1.7B | -- | 1.7B | 1.7B | 1 |
FQ2 2027 (Jun 2027) | 1.67B | -- | 1.67B | 1.67B | 1 |
FQ1 2027 (Mar 2027) | 1.59B | -- | 1.59B | 1.59B | 1 |
FQ4 2026 (Dec 2026) | 1.61B | -- | 1.61B | 1.61B | 1 |
FQ3 2026 (Sep 2026) | 1.47B | -- | 1.47B | 1.47B | 1 |
FQ2 2026 (Jun 2026) | 1.43B | -4.56 | 1.43B | 1.43B | 1 |
FQ1 2026 (Mar 2026) | 1.42B | -3.15 | 1.42B | 1.42B | 1 |
FQ4 2025 (Dec 2025) | 1.44B | 6.69 | 1.44B | 1.44B | 1 |
FQ3 2025 (Sep 2025) | 1.28B | -15.51 | 1.28B | 1.28B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.66564 | 1.41 | -0.25564 | -18.13% |
FQ1 2025 (Mar 2025) | 1.63858 | 0.42 | -1.21858 | -290.14% |
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | 1.43 | 1.43 | 100% | |
FQ2 2024 (Jun 2024) | 1.59 | 1.59 | 100% | |
FQ1 2024 (Mar 2024) | 1.57 | 1.57 | 100% | |
FQ4 2023 (Dec 2023) | 1.79 | 1.79 | 100% | |
FQ4 1993 (Oct 1993) | 0.0689 | 0.0689 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $1.25B | $1.49B | $245.11M | 16.44% |
FQ1 2025 (Mar 2025) | $1.27B | $1.47B | $196.54M | 13.38% |
FQ4 2024 (Dec 2024) | $0B | $1.35B | $1348.25M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.48B | $1475.86M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.47B | $1465.26M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.42B | $1417.69M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.13B | $1131M | 100% |
FQ4 1993 (Oct 1993) | $0B | $0.03B | $28M | 100% |